Publications by authors named "Michael A Spinner"

Claim this Profile
E
Emerging immunotherapies in the Hodgkin lymphoma armamentarium.
Michael A Spinner, Ranjana H Advani

Expert Opin Emerg Drugs· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era.
Sanjal H Desai, Michael A Spinner, Andrew M Evens, Alice Sykorova, Veronika Bachanova

Blood Adv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Survivors and Failures of CAR-T Therapy for Lymphoma: Is there a Role for Allogeneic Transplantation After the CAR-T Crash?
Michael A Spinner, Krishna V Komanduri

Transplant Cell Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort.
Jackson T Bowers, Jacob Anna, Steven M Bair, Kaitlin Annunzio, Narendranath Epperla, Michael A Spinner

Blood Adv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Treatment for Relapsed/Refractory Classic Hodgkin Lymphoma in the Era of Immunotherapy.
Michael P Randall, Michael A Spinner

Cancers (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents.
Michael A Spinner, R A Sica, John S Tamaresis, Ying Lu, Cheryl Chang

Blood· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma.
Sanjal H Desai, Michael A Spinner, Kevin David, Veronika Bachanova, Gaurav Goyal

Am J Hematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience.
Muhammad Saad Hamid, Sarah C Rutherford, Hyejeong Jang, Seongho Kim, Krish Patel, Michael A Spinner

Clin Lymphoma Myeloma Leuk· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased double-negative αβ+ T-cells reveal adult-onset autoimmune lymphoproliferative syndrome in a patient with IgG4-related disease.
Nivaz Brar, Michael A Spinner, Matthew C Baker, Ranjana H Advani, Yasodha Natkunam

Haematologica· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.
Victor Manuel Orellana-Noia, Daniel R Reed, Ashley Alesia McCook, Jeremy Michael Sen, Christian M Barlow, Michael A Spinner

Blood· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Frontline Treatment of Diffuse Large B-Cell Lymphoma.
Michael A Spinner, Ranjana H Advani

Oncology (Williston Park)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Manifestations of GATA2 Deficiency.
Beatriz E Marciano, Kenneth N Olivier, Les R Folio, Christa S Zerbe, Amy P Hsu, Michael A Spinner

Chest· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma.
Reid W Merryman, Luca Castagna, Laura Giordano, Vincent T Ho, Paolo Corradini, Michael A Spinner

Leukemia· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Genome-Wide Binding Profile for Human RE1 Silencing Transcription Factor Unveils a Unique Genetic Circuitry in Hippocampus.
James C McGann, Michael A Spinner, Saurabh K Garg, Karin A Mullendorff, Randall L Woltjer

J Neurosci· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project.
Ranjana H Advani, Tetiana Skrypets, Monica Civallero, Michael A Spinner, Martina Manni

Blood· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD20-Negative Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A 20-Year Consecutive Case Series From a Tertiary Cancer Center.
Joshua R Menke, Michael A Spinner, Yasodha Natkunam, Roger A Warnke, Ranjana H Advani

Arch Pathol Lab Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma.
Reid W Merryman, Robert A Redd, Taiga Nishihori, Julio Chavez, Yago Nieto, Michael A Spinner

Blood Adv· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Checkpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapy.
Nicole A Carreau, Philippe Armand, Reid W Merryman, Ranjana H Advani, Michael A Spinner

Br J Haematol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy.
Nicole A Carreau, Orrin Pail, Philippe Armand, Reid Merryman, Ranjana H Advani, Michael A Spinner

Oncologist· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Conserved Role for Vezatin Proteins in Cargo-Specific Regulation of Retrograde Axonal Transport.
Michael A Spinner, Katherine Pinter, Catherine M Drerup, Tory G Herman

Genetics· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma.
Paola Ghione, Promie Faruque, Neha Mehta-Shah, Venkatraman Seshan, Neval Ozkaya, Michael A Spinner

Blood Adv· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Treatment Beyond Progression with Immune Checkpoint Blockade in Hodgkin Lymphoma.
Reid W Merryman, Nicole A Carreau, Ranjana H Advani, Michael A Spinner, Alex F Herrera

Oncologist· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ex vivo drug screening defines novel drug sensitivity patterns for informing personalized therapy in myeloid neoplasms.
Michael A Spinner, Alexey Aleshin, Marianne T Santaguida, Steven A Schaffert, James L Zehnder

Blood Adv· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Multiply Relapsed or Refractory Adult Large B-Cell Lymphoma.
John K Lin, Lori S Muffly, Michael A Spinner, James I Barnes, Douglas K Owens

J Clin Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort.
Michael A Spinner, Vanessa E Kennedy, John S Tamaresis, Philip W Lavori, Sally Arai

Blood Adv· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis